J Biol Chem, Vol. 274, Issue 51, 36379-36386, December 17, 1999
Reactions of Type II Restriction Endonucleases with 8-Base
Pair Recognition Sites*
Denzil T.
Bilcock,
Lucy E.
Daniels,
Abigail J.
Bath, and
Stephen E.
Halford
From the Department of Biochemistry, School of Medical Sciences,
University of Bristol, University Walk,
Bristol BS8 1TD, United Kingdom
 |
ABSTRACT |
Type II restriction endonucleases usually
recognize 4-6-base pair (bp) sites on DNA and cleave each site in a
separate reaction. A few type II endonucleases have 8-bp recognition
sites, but these seem unsuited for restriction, since their sites are
rare on most DNA. Moreover, only one endonuclease that recognizes a
target containing 8 bp has been examined to date, and this enzyme,
SfiI, needs two copies of this site for its DNA cleavage
reaction. In this study, several endonucleases with 8-bp sites were
tested on plasmids that have either one or two copies of the relevant sequence to determine if they also need two sites. SgfI,
SrfI, FseI, PacI, PmeI,
Sse8781I, and SdaI all acted through equal and independent reactions at each site. AscI cleaved the DNA
with one site at the same rate as that with two sites but acted
processively on the latter. In contrast, SgrAI showed a
marked preference for the plasmid with two sites and cleaved both sites
on this DNA in a concerted manner, like SfiI. Endonucleases
that require two copies of an 8-bp sequence may be widespread in
nature, where, despite this seemingly inappropriate requirement, they
may function in DNA restriction.
 |
INTRODUCTION |
The recognition sequences for the majority of the ~3,000 type II
restriction endonucleases identified to date are symmetrical palindromes of DNA, 4-6-bp1-long, although ~20 enzymes
of this type recognize 8-bp targets (1). The latter are
particularly valuable as tools for the analysis of genomic DNA because
they usually cleave DNA into larger DNA fragments than the enzymes
cutting at 4- or 6-bp sequences, due to the relative rarity of their
sites (2). However, doubts exist over whether a restriction enzyme with
an 8-bp site could provide a bacterial cell with an effective defense
against foreign DNA (3). Restriction demands at least one recognition
site on the incoming DNA, and its efficiency increases with the number of sites (4). The probability of DNA escaping restriction, by being
modified at all sites before being cleaved at any one site, declines
logarithmically with the number of sites. Yet an 8-bp sequence must
occur less frequently on DNA than any 4- or 6-bp element from that
sequence, so phage or plasmid DNA may often lack an 8-bp site or
contain only a small number of such sites. Hence, if the defense
against phage infections by a restriction-modification system confers a
selective advantage to a bacterial cell, evolutionary pressures should
result in a contraction of the length of the recognition sequence
(5).
Most of the current information about the mode of action of type II
restriction enzymes derives from a relatively small number of enzymes,
almost all of which recognize either a 4- or a 6-bp sequence, such as
BamHI, EcoRV, MunI, PvuII,
or TaqI (Refs. 6-10, and references therein). In each of
these examples, the protein is a dimer of identical subunits that
interacts symmetrically with a palindromic DNA sequence, so that the
two active sites in the enzyme are positioned on the scissile
phosphodiester bonds in each strand. In the presence of
Mg2+, the cofactor for DNA cleavage, the two strands are
cut in parallel reactions. The cleavage of both strands is normally
completed before the enzyme dissociates from the DNA, although, in some instances, the enzyme dissociates after cutting just one strand and
then returns to that site to cut the second strand (11). On DNA with
multiple sites, these enzymes usually act in a distributive manner at
each individual copy of the recognition sequence. However, they
sometimes act processively on a DNA with two or more sites. For
example, EcoRI can cleave one site, translocate to another site by an intramolecular process, cut that site, and only then leave
the DNA (12, 13). Conversely, the restriction enzymes in the type IIe
group, such as EcoRII and NaeI, require two
copies of their recognition sequence (14, 15). Both EcoRII
and NaeI are reported to be homodimeric proteins that have
two distinct DNA-binding sites. One binding site has the catalytic
functions for DNA cleavage, but this remains inactive unless a second
copy of the recognition sequence binds to an allosteric site elsewhere in the dimer (16-18). The DNA at the allosteric site is not cleaved (19, 20).
To date, a reaction mechanism has been established for only one of the
type II enzymes that recognizes a site with 8 specified bp: the
SfiI endonuclease from Streptomyces fimbriatus
(21-27). In contrast to both the orthodox enzymes such as
EcoRV and the type IIe enzymes such as EcoRII,
SfiI is a tetrameric protein that has two identical binding
sites for its palindromic recognition sequence, each presumably made
from two subunits. However, SfiI has no activity when only
one DNA-binding site is occupied. Instead, it has to bind two copies of
its recognition sequence before being able to cleave DNA. The two sites
can be in cis, on the same molecule of DNA, or in
trans, on separate molecules of DNA. In the former case,
SfiI tethers the intervening DNA in a loop, while, in the latter, it bridges the two DNA molecules. As with other proteins that
span two sites (28), SfiI prefers sites in cis
over sites in trans. It generally cleaves plasmids with two
sites more rapidly than plasmids with one site. Moreover, the turnover
of SfiI on plasmids with two sites is normally completed by
the liberation of DNA cut in both strands at both sites; only a small
fraction of the DNA is liberated after cutting just one site. The
concerted action of SfiI at two recognition sites is
reminiscent of the enzymes that mediate DNA rearrangements by
site-specific recombination or transposition (29), but a role for
SfiI in re-arrangements has been rejected (30). Like the
orthodox restriction enzymes (31), phosphodiester hydrolysis by
SfiI inverts the stereoconfiguration of the phosphate, so
its reaction cannot involve a covalent enzyme-DNA intermediate (32).
Enzymes that catalyze both DNA breakage and religation normally
conserve the energy of the phosphodiester bond, a prerequisite for the
religation step, by forming a covalent intermediate (29).
In vivo, SfiI can restrict DNA that has two or
more SfiI sites, but it is incompetent at restricting DNA
with one site (30). The mode of action of SfiI thus
exacerbates the doubts over whether an enzyme recognizing an 8-bp
sequence could defend a cell against phage or plasmid DNA. However, the
recognition sequence for SfiI is unusual (33) in that it
contains 8 specified bp but these are interrupted by a unspecified
spacer of 5 bp (Table I). Apart from one isoschizomer of
SfiI, all of the other type II enzymes that cleave DNA at
8-bp sites recognize uninterrupted sequences of 8 consecutive bp (Table
I). Hence, while the type II enzymes with continuous recognition sites
of 8 bp might act like SfiI, they may differ from
SfiI and behave instead like the orthodox enzymes such as
BamHI or EcoRV. These possibilities were examined by assaying several restriction enzymes on plasmids that have either
one or two copies of the relevant sequence in order to determine
whether they act concertedly at two sites or cleave each site in a
separate reaction.
 |
EXPERIMENTAL PROCEDURES |
Enzymes--
Restriction endonucleases were purchased from the
following suppliers: AscI, FseI, PacI,
PmeI, Sse8387I, SacI, SalI,
and SphI from New England Biolabs; SgfI from
Promega; SrfI from Stratagene; and SdaI from
Fermentas; SgrAI from both Roche Molecular Biochemicals and
New England Biolabs (with equivalent results). Enzyme concentrations are given in terms of units of enzyme activity, as specified by the
supplier. Other enzymes were obtained from New England Biolabs or Roche
Molecular Biochemicals.
DNA--
The plasmids pAT153 (34) and pNEB193 (New England
Biolabs) have been described before; the latter is identical to pUC19 (35) except for an enlarged multiple cloning site (MCS) with a number
of additional restriction sites. Two derivatives of pAT153, pDB7 and
pDB8 (Fig. 1a), and one of pNEB193, pAB1 (Fig.
1b), were constructed by standard methods (36). The duplex
used in the construction of pDB7 was produced by annealing two 50-base
synthetic oligodeoxynucleotides that were complementary to each other
except for 4 bases at their 5' termini; the resultant 46-bp duplex had 4-base 5'-extensions that matched an EagI terminus at one
end and a StyI terminus at the other (Fig. 1a).
The SgrAI site in this duplex had the same sequence as the
intrinsic site on pAT153, with respect to both its purine/pyrimidine
degeneracies (Table I) and to its flanking sequence for 3 bp on either
side. The duplex used in the construction of pDB8 was made by the same
procedure; it had the same sequence as the duplex for pDB7, except that
it lacked the SgrAI site and its 4-base 5'-extensions
matched, respectively, EcoRI and HindIII termini
(Fig. 1a). The plasmids were used to transform
recA strains of Escherichia coli, either HB101
(36) or ER2238 (37). The transformants were cultured in M9 minimal medium with 1 mCi/liter [methyl-3H]thymidine,
and the covalently closed form of the plasmid was purified by density
gradient centrifugations (38). The preparations were largely
supercoiled monomeric plasmid, with <10% as either dimeric plasmid or
nicked open circle DNA.
Assays--
Reactions were carried out at 37 °C in 200-µl
volumes and were initiated by adding the restriction enzyme (typically
10 units) to the requisite plasmid (10 or 20 nM) in an
appropriate buffer. In the first instance, the buffer used with each
enzyme was that advised by the supplier. To test for processivity (12),
most enzymes were also examined in modified buffers with elevated ionic strengths. For enzymes where the recommended buffer contains NaCl, the
modified buffer had double the concentration of NaCl. Similarly, buffers with KOAc were adjusted to twice the advised level of KOAc. At
various times after adding the enzyme, aliquots (15 µl) were removed
from the reactions and mixed immediately with 10 µl of an EDTA stop
mix (38). The samples were analyzed by electrophoresis through agarose
under conditions that separated the supercoiled substrate and each of
the various products from the reaction (Fig. 2). The segments of the
agarose gel that encompassed the substrate and each product were
analyzed individually by scintillation counting to yield the
concentration of each form of the DNA at each time point (38). For
plasmids with two recognition sites, the two linear DNA fragments (L1
and L2) arising from cleavage at both sites were counted together to
obtain a single value for the concentration of doubly cut DNA
(L1/2).
Experimental Strategy--
A distinction between the different
modes of action seen among the type II restriction enzymes can be made
by analyzing the reaction kinetics of the enzyme on two substrates, one
with one copy of its recognition sequence and another with two copies.
An orthodox enzyme like EcoRV will cleave a circular DNA
with one copy of its recognition site first in one strand, converting the supercoiled (SC) substrate to the nicked open circle (OC) form of
the DNA, and then in the second strand to produce the full-length
linear (FLL) form (Fig. 2a). However, the hydrolysis of both
phosphodiester bonds is often much faster than the dissociation of the
cleaved DNA (8, 13, 39). In these cases, the nicked form exists only as
a transient enzyme-bound intermediate, and the sole product that
accumulates during a steady-state reaction is the FLL form. A SC DNA
with two sites will be cleaved by an orthodox enzyme acting
distributively first at one site to yield FLL DNA and then at the other
site to give two linear fragments, L1 and L2 (Fig. 2b). The
reaction on a two-site DNA should therefore follow a sequential A
B
C pathway, where the concentration of B first rises and then falls
in a manner specified by the relative rates of the A
B and the B
C steps and where the formation of C is preceded by a
characteristic lag phase (40). If the recognition sites on the one- and
two-site substrates are all equal to each other, then the initial rate
for the utilization of the SC DNA with one site
(v1) should equal that for the utilization of
the SC DNA with two sites (v2A), and the latter
should also equal the rate for the conversion of the FLL DNA to L1 and
L2 (v2B).
A type II restriction enzyme that acts processively on a DNA with
multiple sites should also utilize the two-site substrate at the same
rate as the one-site substrate. But if the enzyme then travels along
the DNA to another site and cuts that site before departing from the
DNA, the SC substrate with two sites will be converted quickly to the
doubly cut products, without an intervening accumulation of FLL DNA and
without a lag phase preceding the formation of L1 and L2. However, the
processivity is unlikely to be 100% efficient, and the enzyme will
sometimes depart from the DNA before cutting the second site.
Nevertheless, processivity will diminish the yield of FLL DNA from the
two-site substrate, relative to that from an orthodox enzyme acting
distributively. Moreover, the degree of processivity is likely to
decrease as the ionic strength of the reaction is increased (12, 13). Hence, an enzyme that acts processively at low ionic strength is likely
to act in a distributive manner at high ionic strength.
In contrast, a restriction enzyme that follows the mechanism proposed
for the type IIe enzymes will utilize the substrate with two sites more
rapidly than that with one site, since the interaction with the second
site, which is needed to activate the enzyme, will be aided if this is
provided in cis rather than in trans. Having
cleaved one site on a two-site substrate, a type IIe enzyme would
cleave the residual site at a slow rate, so a large amount of FLL DNA
should accumulate during the reaction.
An enzyme that acts concertedly at two recognition sites, like
SfiI, would also utilize a two-site plasmid more rapidly
than a one-site plasmid. However, in contrast to a type IIe enzyme, a
concerted reaction on a two-site plasmid will give directly the final
products cut at both sites, L1 and L2. A diminished yield of FLL DNA
from a SC DNA with two sites could thus be due to either concerted or
processive actions, but these can be distinguished by analyzing the
reactions at varied ionic strengths. Both the difference in the
reaction rates of SfiI on plasmids with one or two sites and
the degree of concertedness on plasmids with two sites depend on the
concentration of NaCl in the reaction (22). In reactions lacking NaCl,
SfiI cleaves DNA with one site almost as readily as DNA with
two sites; under these conditions, the protein binds to its recognition
sites with sufficiently high affinity so that even the relatively weak
interactions with sites in trans still permit the maximal
reaction rate (27). A small amount of salt prevents the interactions in
trans, so SfiI reactions on DNA with one site are
blocked at lower levels of NaCl than those on DNA with two sites (22).
In high salt, SfiI cleaves DNA with two sites much more
rapidly than DNA with one site. But the progressive destabilization of
the complex of SfiI and two DNA sites with increasing ionic
strength results in the progressive liberation of products from the
two-site substrate that have been cleaved in three, two, or one
phosphodiester bonds in place of the product cleaved at both sites
in both strands (25, 26).
The reaction kinetics of a restriction enzyme on one-site and two-site
substrates thus provide a diagnostic test for the mode of action of the
enzyme; for independent reactions at individual sites,
v1 = v2A = v2B; for processive action on a DNA with two sites, v1 = v2A < v2B; for activation by a second site,
v1 < v2A > v2B; for concerted action at two sites,
v1 < v2A < v2B. However, data at one ionic strength that
yield a match to one of the above sets of relative values for
v1, v2A, and
v2B may be insufficient for the diagnosis. An
unambiguous distinction between these possibilities requires data at
varied ionic strengths.
A meaningful comparison of the activities on one- and two-site
substrates requires the following conditions to be met. First, the
plasmids must be isolated from recombination-deficient strains to
prevent the one-site DNA from recombining to its dimeric form with two
sites; recA strains were used here. Second, the DNA
sequences flanking each recognition site on the two substrates must all be the same, since restriction activity is often affected by the flanking DNA (41-43); plasmid substrates were designed to meet this
requirement (Fig. 1). Third, the two-site substrate must have an
appropriate length of DNA between the sites. Lengths of <300 bp may be
inappropriate, because DNA looping between closely spaced sites depends
on both the helical periodicity and the bending of the intervening DNA
(26). Conversely, on linear DNA, the stability of a loop between sites
separated by >300 bp decreases as the separation increases, but this
effect is largely nullified by DNA supercoiling (28). On SC DNA,
increasing the separation of the sites above 400 bp has at most only a
marginal effect on loop stability (44, 45). All of the tests described
here used SC plasmids with, in the case of the two-site substrates,
>500 bp between the sites. Fourth, the reactions must employ lower concentrations of enzyme than substrate. Otherwise, the enzyme may bind
independently to each site on the two-site DNA and cleave this DNA at
double the rate of the one-site DNA.
This study used commercial preparations of restriction enzymes, whose
concentrations were specified in terms of units of activity rather than
molarity. Nevertheless, the reactions are likely to have used lower
concentrations of enzyme than DNA. For several enzymes, varied numbers
of units were added to the reactions, and in all cases, the reaction
velocities increased linearly with the number of units (data not
shown). This behavior is characteristic of a steady-state reaction with
substrate in excess of the enzyme. If the reactions had contained
enzyme in excess of substrate, the rates would not have varied with the
amount of enzyme. A further concern arises from the use of SC
substrates. If an enzyme is more active on SC DNA than on linear DNA
(or vice versa), the rate for the conversion of a SC DNA
with two sites to the FLL form will differ from that for the subsequent
conversion of FLL DNA to L1 and L2. Several of the enzymes were
therefore tested on both SC and linear DNA substrates, the latter being
generated by cleaving the plasmid with another restriction enzyme; in
all cases, the SC and linearized substrates gave the same reaction rates (data not shown).
 |
RESULTS |
SgfI, SrfI, SgrAI, and FseI--
The above strategy was applied
first to a set of four enzymes with 8-bp recognition sites:
SgfI, SgrAI, SrfI, and
FseI. The first three of these were selected because they,
like SfiI, are from Streptomyces species (Table
I). FseI was chosen because its recognition sequence is the same as that for SfiI except
for the absence of the 5-bp interruption in the SfiI site
(Table I). Plasmids with one or two recognition sites for each enzyme
were constructed from pAT153, which has one site for SgrAI
and none for the other enzymes (Fig.
1a). The first construct,
pDB7, contains two sites for SgrAI, separated by 571 bp, and
one site for the other enzymes. The second, pDB8, contains two sites
for SgfI, SrfI, and FseI, separated in
each case by 949 bp.
View this table:
[in this window]
[in a new window]
|
Table I
Recognition sequences
The names, the species of origin, and the recognition sequences (1) for
all of the restriction enzymes examined here are listed.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Construction of plasmid substrates.
a, the plasmid pAT153 was cleaved with EagI and
StyI and ligated to an oligonucleotide duplex whose sequence
included individual recognition sites for SgrAI,
SgfI, SrfI, and FseI. The resultant
plasmid, pDB7, was cleaved with EcoRI and HindIII
and ligated to an oligonucleotide duplex whose sequence included
individual recognition sites for SgfI, SrfI, and
FseI to yield pDB8. The vector, pAT153, has one recognition
site for SgrAI; pDB7 has two sites for SgrAI and
one each for SgfI, SrfI, and FseI; and
pDB8 has two sites for SgfI, SrfI, and
FseI. b, the plasmid pNEB193 was cleaved with
PvuII, and the fragment spanning the MCS, shown in
gray shading, was isolated by electrophoresis and
ligated to a second sample of pNEB193 that had been cleaved with
SspI. The MCS in pNEB193 has solitary recognition sites for
AscI, PacI, PmeI, and
Sse8387I (SdaI) and also, not shown, for
SacI, SalI, and SphI, while pAB1 has
two copies of each of these sites.
|
|
For each enzyme, parallel experiments were carried out on the one-site
and two-site plasmids. Samples were withdrawn from the reactions at
varied times and analyzed by electrophoresis through agarose. Typical
gels, from SgfI reactions on pDB7 and pDB8, are shown in
Fig. 2, a and b,
respectively (others not shown). With both plasmids, the intact SC, the
nicked OC, and the FLL forms of the DNA were isolated from each other,
as were the fragments produced by cutting both sites on the two-site
DNA, L1 and L2. The concentrations of each form of the DNA, at each
time point sampled during the reaction, were then determined (Fig.
3). Rates for the utilization of the one-
and two-site substrates, v1 and v2A, respectively, were measured from the
initial linear decline in the concentration of SC DNA with time, while
the rate for the second reaction on the two-site substrate,
v2B, was assessed relative to
v2A from the time course for the production and
decay of the FLL DNA. If v2A = v2B, the maximal amount of FLL DNA produced during the reaction will be 40% of the total DNA, but if the amount of
FLL DNA rises to a maximum of >40% of the total DNA, then
v2A > v2B; conversely, a
maximum of <40% indicates that v2A < v2B (modeling not shown).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2.
Reactions of a type II endonuclease on
plasmids with one or two recognition sites. The reactions
contained 50 units·ml 1 SgfI and 20 nM DNA (~95% supercoiled) in 10 mM
Tris·HCl (pH 7.9), 100 mM NaCl, 10 mM
MgCl2, and 1 mM dithiothreitol, at 37 °C.
The DNA in a was pDB7, which has one SgfI site,
and the DNA in b was pDB8, which has two SgfI
sites. At timed intervals after adding the enzyme, samples from the
reactions were quenched with stop mix and analyzed by electrophoresis
through agarose. The schematics in both a and
b illustrate the various forms of DNA that can exist during
these reactions. The agarose gels in both a and b
illustrate the separation of these forms of the DNA; the
electrophoretic mobility of each form is marked on the right
of the gels. The reaction times (0-120 min) are noted as
expanding scales above the
gels.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
SgfI on plasmids with one or two
recognition sites. The reactions of SgfI on pDB7 (which
has one SgfI site) (a) or pDB8 (two
SgfI sites) (b) that are shown in Fig. 2,
a and b, respectively, were analyzed to obtain
the concentrations of the following forms of the DNA at each time point
during the reaction: , SC; , OC; , FLL; (only in
b), total DNA in the two final products cut at both sites
(L1/2). The plasmids were 3H-labeled, and the DNA
concentrations were determined by assessing individual segments of the
agarose gels (Fig. 2) in a scintillation counter.
|
|
The reaction of SgfI on a SC plasmid with one cognate site
yielded virtually none of the OC DNA. Instead, almost all of the substrate was converted directly to the FLL product (Fig.
3a). Thus, as with many other restriction enzymes (11),
SgfI cuts its recognition site in both strands before
dissociating from the DNA. SgfI again yielded virtually none
of the OC DNA from the plasmid with two SgfI sites, and the
only product formed in significant yield during the initial period of
this reaction was FLL DNA; the FLL DNA was subsequently cleaved at the
second site to give L1 and L2 (Fig. 3b). Both the initial
rise in the concentration of FLL DNA, to a maximum of ~40% of the
total DNA, and the lag phase preceding the formation of L1 and L2
denote a sequential A
B
C pathway, with equal rates for the A
B and the B
C steps. Moreover, the rate at which
SgfI utilized the one-site substrate
(v1 = 0.41 nM·min
1)
equaled that for the utilization of the two-site substrate
(v2A = 0.44 nM·min
1). The SgfI endonuclease
thus clearly cleaves DNA by means of independent reactions at
individual sites.
Unlike SgfI, the SrfI and FseI
endonucleases initially generated some OC DNA during their reactions on
their one-site and two-site substrates, pDB7 and pDB8, respectively,
and only later gave FLL DNA. But like SgfI, the rates at
which SrfI and FseI utilized the one-site
substrate were the same as those on the two-site substrate, and the two
sites in pDB8 were cleaved sequentially at equal rates (data not
shown). Thus, both SrfI and FseI also cleave DNA
through independent reactions at individual sites. Indeed, the initial
liberation of OC DNA during the reactions of these two enzymes
indicates that they sometimes dissociate from the DNA after cutting one
site in one strand.
SgrAI, on the other hand, behaved differently on a one-site
substrate, pAT153, compared with a two-site substrate, pDB7 (Fig. 4). In a reaction buffer containing 50 mM KOAc, SgrAI cleaved its single recognition
site on pAT153 in two stages: first in one strand to give OC DNA and
only later in the second strand to linearize the DNA (Fig.
4a). Yet, under the same conditions, SgrAI
cleaved pDB7 in a highly concerted manner; only small amounts of the OC
and FLL forms were released. Instead, the majority of the SC DNA was
converted directly to the products cut at both sites, without a
detectable lag phase (Fig. 4b). Each turnover of
SgrAI on a DNA with one recognition site thus results in the cleavage of one phosphodiester bond, while most of its turnovers on a
DNA with two sites result in the cleavage of four phosphodiester bonds.
Furthermore, the rate at which SgrAI utilized the two-site substrate (v2A = 1.52 nM·min
1) was faster than the one-site
substrate (v1 = 0.32 nM·min
1). The different kinetics of
SgrAI on substrates with one or two recognition sites
therefore eliminate the possibility that this enzyme acts through
independent reactions at individual sites. In addition, while the
enhanced reaction rate on pDB7 is consistent with SgrAI
being a type IIe enzyme, the lack of accumulation of FLL DNA during
this reaction discounts this possibility.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
SgrAI on plasmids with one or two
recognition sites. Reactions at 37 °C contained 50 units·ml 1 SgrAI and 20 nM DNA
(~90% supercoiled) in 33 mM Tris acetate (pH 7.9), 10 mM magnesium acetate, 0.5 mM dithiothreitol and
either 50 mM KOAc (left panels;
a and b) or 200 mM KOAc
(right panels; c and d). In
the two upper panels (a and
c), the DNA was pAT153, which has one SgrAI site.
In the two lower panels (b
and d), the DNA was pDB7, which has two SgrAI
sites. Samples taken from the reactions at timed intervals were
analyzed as above to obtain the concentrations of the following forms
of the DNA: SC ( ), OC ( ), FLL ( ), and total DNA in the two
final products cut at both sites (L1/2) ( ; only in b and
d).
|
|
The 5-fold difference in the rates of the SgrAI reactions on
two- and one-site substrates is, however, considerably smaller than the
20-fold difference recorded with SfiI (21, 22). Hence, the
diminished yield of FLL DNA during the SgrAI reaction on
pDB7 (Fig. 4b) might not be due solely to concerted action
at two recognition sites, in the manner of SfiI. Instead, it
may be due, at least in part, to processivity along the DNA. The
reactions of SgrAI on pAT153 and pDB7 were therefore
examined at varied ionic strengths; typical reaction records at an
elevated ionic strength are shown in Fig. 4, c and
d. In parallel, the reactions of an orthodox enzyme,
SgfI, were also examined at varied ionic strengths.
SgfI is optimally active in the presence of NaCl, but
SgrAI is largely blocked by NaCl (data not shown), so the
comparison between SgfI and SgrAI was made by
using KOAc to vary the ionic strength. The rates at which
SgfI cleaved its two-site and one-site substrates both
declined progressively with increasing concentrations of KOAc (data not
shown). Nevertheless, the ratio of SgfI activities on the
two substrates, v2A/v1,
remained at unity at all ionic strengths tested (Fig.
5a). (Similarly, the
v2A/v1 ratios for both
SrfI and FseI were unaffected by doubling the
ionic strengths of their reaction buffers (data not shown).) The rate
at which SgrAI utilized its one-site substrate also declined
progressively with increasing KOAc concentrations (Fig. 4, a
and c). In contrast, the rate at which SgrAI
utilized its the two-site substrate remained essentially constant at
KOAc concentrations of
200 mM (Fig. 4, b and
d) and was only reduced at
250 mM KOAc.
Consequently, the ratio of the reaction rates of SgrAI on
its two- and one-site substrates increased from 3 to 30 as the KOAc
concentration was raised from 0 to 250 mM (Fig.
5b). The diminished yield of FLL DNA during the
SgrAI reaction on pDB7 at 50 mM KOAc (Fig.
4b) therefore cannot be due to processivity.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Ratio of rates on one- and two-site
substrates for SgfI and SgrAI.
Reactions at 37 °C contained 50 units·ml 1
restriction endonuclease and 20 nM DNA (with either one or
two recognition sites for the enzyme in question) in 33 mM
Tris acetate (pH 7.9), 10 mM magnesium acetate, 0.5 mM dithiothreitol, and KOAc at the concentration indicated
on the x axis. a, the endonuclease was
SgfI, and the one- and two-site substrates were pDB7 and
pDB8, respectively. b, the endonuclease was
SgrAI, and the one- and two-site substrates were pAT153 and
pDB7, respectively. In both cases, initial rates for the utilization of
the one-site substrate (v1) and the two-site
substrate (v2A) were measured at each
concentration of KOAc, and the ratios
(v2A/v1) are plotted on
the y axis.
|
|
At all concentrations of KOAc tested, SgrAI initially
cleaved its one-site substrate in just one strand of the DNA to give the OC form (Fig. 4, a and c). However, although
the rate of utilization of the two-site substrate for SgrAI
remained constant as the KOAc concentration was increased to 200 mM, the initial products from its reactions on pDB7 at high
ionic strengths differed from those at low ionic strength. At KOAc
concentrations of
100 mM, SgrAI cleaved its
two-site substrate in a highly concerted manner, converting almost all
of the substrate directly to the final products cut in both strands at
both sites (as noted above at 50 mM KOAc; Fig. 4b). In contrast, at concentrations of KOAc of
125
mM, SgrAI cleaved the two-site substrate in a
sequential series of separate reactions, giving first the OC form and
then the FLL form and only later L1 and L2 (in all cases, as in Fig.
4d). Like SfiI (22), both the difference between
the reaction rates of SgrAI on one- and two-site substrates
and the degree of its concertedness on the two-site substrate vary with
the ionic strength of the reaction buffer. The behavior of
SgrAI on its one- and two-site substrates matches the
expectations for a restriction endonuclease that acts concertedly at
two recognition sites.
Other Restriction Enzymes with 8-bp Sites--
The MCS in pNEB193
contains single copies of the 8-bp sites for AscI,
PacI, PmeI, and Sse8387I (Fig.
1b). A derivative of pNEB193, pAB1, was constructed with two
copies of the MCS in inverted orientation (Fig. 1b). On
pAB1, the distance between the pairs of recognition sites varied from
717 bp for AscI to 803 bp for Sse8387I. The SC
forms of pNEB193 and pAB1 were used as one- and two-site substrates for
these enzymes. An isoschizomer of Sse8387I, SdaI
(Table I), was also examined in the same manner. Both
Sse8387I and SdaI are from
Streptomyces species, and they also have in common with
SfiI a G:C-rich recognition sequence, as does
AscI and all four of the enzymes analyzed above (Table I).
The restriction sites that are 8 bp long generally possess a marked
preponderance (
75%) of either G:C bp or A:T bp (1). PacI
and PmeI provide two examples of the latter (Table I).
When assayed on pNEB193 and pAB1, Sse8387I, SdaI,
PacI, and PmeI all behaved on the one- and
two-site substrates in the same manner as SgfI (see Figs. 2
and 3). All four of these enzymes gave the same rates for the
utilization of the one- and the two-site substrates (data not shown).
All four cleaved the two-site substrate in sequential stages: first at
one site to give FLL DNA and then at the second site to give L1 and L2,
with the same rates for the two stages. This behavior was observed in
both the standard reaction buffer for the enzyme in question and at
elevated ionic strengths. Sse8387I, SdaI,
PacI, and PmeI thus all cleave DNA via
independent reactions at individual recognition sites in the orthodox
manner for type II restriction enzymes.
AscI, however, showed a distinctive pattern of behavior on
pAB1 (Fig. 6). Instead of cleaving this
two-site substrate in sequential stages, first to FLL DNA and then
after a lag phase to L1 and L2, the reaction of AscI on pAB1
at a low ionic strength yielded less of the FLL DNA than expected for a
pathway involving two kinetically equal steps. It also yielded the
doubly cut products directly from the start of the reaction rather than
after a lag phase (Fig. 6a). However, at an elevated ionic
strength, the reaction profile for AscI on its two-site
substrate conformed to the expectations for a two-step sequential
pathway, since it now gave rise first to FLL DNA and only later, after
a lag phase, the doubly cut products (Fig. 6b).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
AscI on a plasmid with two
recognition sites. Reactions at 37 °C contained 24 units·ml 1 AscI and 10 nM pAB1
(~90% supercoiled) in 20 mM Tris acetate (pH 7.9), 10 mM magnesium acetate, 1 mM dithiothreitol, 100 µg/ml bovine serum albumin, and either 20 mM KOAc
(a) or 200 mM KOAc (b). Samples taken
from the reactions at timed intervals were analyzed as above to obtain
the concentrations of the following forms of the DNA: SC ( ), OC
( ), FLL ( ), and total DNA in the two final products cut at both
sites (L1/2; ).
|
|
The reaction of AscI on pAB1 at low ionic strength (Fig.
6a) is consistent with a value for
v2B, the rate for cutting the FLL DNA to L1 and
L2, at twice that for v2A, the rate for
converting the SC substrate to FLL DNA. A possible reason for this
enhancement of v2B over
v2A could be that AscI is more active
on linear DNA than on SC DNA, but this was discounted. Linear DNA
substrates were cleaved by AscI at the same rate as SC
substrates (data not shown). Moreover, the data at the elevated ionic
strength (Fig. 6b) is consistent with a value for
v2B that is only 1.2 times higher that that for
v2A. In addition, the rates at which
AscI utilized its one-site substrate, pNEB193, were the same
as those for its two-site substrate, pAB1; at 20 mM KOAc,
v1 = 0.52 nM·min
1
and v2A = 0.51 nM·min
1.
The diminished yield of FLL DNA during the reactions of AscI
on its two-site substrate at low strength is therefore not due to
concerted action at two recognition sites in the manner of SfiI. Instead, AscI appears to be capable of a
high degree of processivity between two recognition sites, even when
these are separated by 717 bp. At low ionic strength, AscI
presumably binds to one recognition site, cleaves the DNA at that site,
and then translocates to the second site by an intramolecular process, without leaving the DNA. One turnover of the enzyme can then result in
the cleavage of two separate sites on the DNA. Similar transfers between recognition sites were noted previously with EcoRI
(12, 13) although over shorter distances than those recorded here with
AscI. However, as with EcoRI, processivity by
AscI is abolished by raising the ionic strength.
Streptomyces Restriction Enzymes--
Two enzymes that act
concertedly at 8-bp recognition sites are SfiI (23) and
SgrAI (this study), which both originate from Streptomyces species. To determine whether concerted action
at two sites is a common feature of Streptomyces restriction
enzymes, some endonucleases from Streptomyces species that
have 6-bp recognition sites were examined by the above procedure. The
MCS on pNEB193 has single sites for three such enzymes,
SacI, SalI, and SphI (Table I), so
pAB1 carries two copies of these recognition sequences (Fig.
1b). Previous studies on the kinetics of DNA cleavage by SalI (46) had only used substrates with one recognition
site, thus leaving open the possibility that SalI would
display enhanced activity on a DNA with two sites. No studies on the
kinetics of SacI and SphI have been reported to
date. However, SalI, SacI, and SphI
all displayed the same activity on the one-site substrate, pNEB193, and
the two site-substrate, pAB1, and they all cleaved the latter by means
of independent reactions at individual sites (data not shown).
 |
DISCUSSION |
Type II restriction enzymes are, conventionally, dimeric proteins
that cleave DNA at individual sites (11), but SfiI is a
tetramer that cleaves DNA only after binding to two copies of its
recognition sequence (25). When the mechanism of SfiI was first characterized (21), no other type II enzyme was known to operate
in this manner. SfiI is distinct from the type IIe enzymes
such as EcoRII and NaeI (24). It carries out
concurrent DNA cleavage reactions at two identical binding sites for
its cognate DNA (23, 27), whereas the type IIe enzymes seem to have two
dissimilar binding sites, with the DNA at one site acting solely as an
activator for catalysis at the other site (15-18). In this study, a
screen was developed to search for other endonucleases that require two
sites for their catalytic reactions. The kinetics of a restriction
enzyme on plasmids that have either one or two recognition sites for
the enzyme were shown to provide a clear cut distinction between the
following schemes: separate reactions at individual sites; processivity
by translocation from one site to another without leaving the DNA;
activation by a second copy of the recognition sequence, as in the type
IIe systems; and concerted action at two recognition sites, like
SfiI. The test was applied to 12 different endonucleases
that recognize 8-bp sequences and/or come from Streptomyces
species in the belief that these would be the most likely to act like
SfiI.
Ten of the enzymes behaved in the conventional manner and cleaved
individual sites in independent reactions. These included several
Streptomyces enzymes that recognize either 8-bp sequences (SgfI, SrfI, Sse8387I, and
SdaI) or 6-bp sequences (SacI, SalI, and SphI). The Streptomyces enzymes that
recognize 8-bp sites all act at G:C-rich sequences (Table I), but
conventional behavior was also observed with other enzymes whose 8-bp
sites are either G:C-rich, such as FseI, or A:T-rich, such
as PacI and PmeI. Concerted action at two
recognition sites is clearly not a universal feature of the restriction
enzymes that recognize 8-bp sequences nor of those from
Streptomyces species. However, two enzymes deviated from the
conventional pattern. In one case, AscI, the cleavage of the
two-site substrate matched the expectation for a processive enzyme, at
least at low ionic strength (Fig. 6a). The translocation of
an enzyme from one specific site to another must involve a succession
of transient associations with nonspecific DNA. Perhaps AscI
dissociates from nonspecific DNA at a slower rate than the other
enzymes tested here. The other exception, SgrAI, showed the pattern expected for an enzyme acting concertedly at two
recognition sites. None of the 12 enzymes followed the pathway proposed
for the type IIe enzymes.
The kinetics of SgrAI on one-site and two-site substrates
show that this enzyme needs two sites for optimal activity. On a DNA
with one site, SgrAI presumably acts in trans,
bridging sites on separate molecules, but the resultant complex has too
short a lifetime to allow the enzyme to cleave more than one
phosphodiester bond before it breaks down (Fig. 4a). On a
DNA with two sites, SgrAI would act preferentially in
cis, looping out the DNA between two sites on the same
molecule. At low ionic strength, the lifetime of the complex with sites
in cis is long enough to allow the enzyme to cut both
strands at both sites before it falls apart (Fig. 4b). The
looped complex is likely to have a shorter lifetime at high ionic
strength so that the enzyme then has only enough time to cut one
phosphodiester bond (Fig. 4d). Nevertheless, as expected given the relative stabilities of DNA-protein complexes in
cis over those in trans (28), elevated ionic
strengths reduced SgrAI activity on the one-site DNA more
severely than that on the two-site DNA (Fig. 5). In these respects,
SgrAI behaves like SfiI (22). However, while the
ability of SgrAI to cleave four phosphodiester bonds in one
turnover suggests a tetrameric structure, this has yet to be
established. In further experiments on
SgrAI,2 the ratio
of its activities on two- and one-site DNA increased with increasing
concentrations of the protein, thus raising the possibility that
SgrAI may exist as an inactive dimer and that two DNA-bound
dimers associate to form an active tetramer.
The recognition sequence for SfiI contains a 5-bp
interruption amid 8 specified bp and thus covers 13 bp, longer than is
usual for a restriction site (Ref. 33; Table I). Hence, it has been suggested that SfiI is a special case among restriction
enzymes and that its unusual reaction mechanism is due to the length of its recognition site (47). However, the recognition site for SgrAI is a continuous sequence of 8 bp. Moreover, it has
recently been found that Cfr10I, an enzyme that recognizes a
continuous sequence of 6 bp, operates in exactly the same way as
SfiI (47). Like SfiI (21, 25), Cfr10I
is a tetramer instead of the dimer proposed previously (48). Again,
like SfiI (23, 26), Cfr10I interacts with two
sites to loop out the intervening DNA (47). The requirement of
SfiI for two recognition sites is therefore not a
consequence of either the length or the discontinuity of its
recognition site but is instead due to a mechanism that now appears to
be widespread among type II restriction enzymes. Strikingly, the
recognition sequence for Cfr10I is the central 6 bp of the 8-bp site for SgrAI. Different restriction enzymes often
follow similar reaction mechanisms (e.g. EcoRV
and TaqI) (7, 10). The similarities in mechanism have not,
however, been accompanied previously by similarities in recognition sequence.
Endonucleases that need two recognition sites might seem to be less
suited for restriction in vivo than enzymes acting at a
single site, especially with 8-bp sites. In a random sequence containing equal amounts of A, T, G, and C, an 8-bp sequence occurs statistically once per 66 kb (for the degenerate SgrAI site
(Table I), once per 16 kb). When 2 megabase pairs of Streptomyces
coelicolor DNA was analyzed for restriction sites for the
Streptomyces enzymes that recognize 8-bp sequences (30), the
sites for several of the enzymes occurred at frequencies close to the
statistical expectation. But interestingly, the enzymes whose 8-bp
sites occur most frequently in this DNA are those that need two sites
for their reactions, namely SgrAI and SfiI.
Recognition sites for SgrAI and SfiI were found
in S. coelicolor DNA at mean intervals of 1.3 and 2.7 kb, respectively (30). Thus, while SgrAI and SfiI
sites may be rare in DNA from other species, they are remarkably common
in Streptomyces DNA. If the DNA targets for restriction
in vivo by SgrAI or SfiI are as rich
in these sites as S. coelicolor DNA, then the enzymes would
have no difficulty in locating two sites on the target and restricting
it. In addition to these type II enzymes, many other restriction
systems employ endonucleases that require two sites on the target DNA:
the type III systems (49), some methylation-specific systems (50), and,
in some situations, the type I systems (51). The reason why
SfiI interacts with two recognition sites is to ensure that
it cleaves DNA only at its cognate sequence. It cannot form synaptic
complexes with noncognate DNA or with one cognate and one noncognate
site, and only the synaptic complex with two cognate sites is
catalytically active (27). The same rationale may apply to
SgrAI and to Cfr10I.
Of the 10 restriction enzymes with 8-bp sites analyzed here and in
previous studies (21), only SfiI and SgrAI were
found to act concertedly at two copies of their recognition sequences. Hence, it might seem that concerted action at two sites is relatively uncommon among these enzymes, but this may not be so. Almost all restriction enzymes identified to date were discovered by assaying cell-free extracts of bacterial cultures for the fragmentation of a
test DNA, usually phage
or adenoviral DNA (11). However, if an
endonuclease needs two copies of an 8-bp sequence separated by an
appropriate length of DNA, the test DNA may not be a substrate. For
example, there are no SfiI sites on phage
DNA, and the
SfiI endonuclease was discovered by assaying extracts from
S. fimbriatus on adenoviral DNA (33). Fortuitously,
adenoviral DNA contains two SfiI sites separated by 1 kb,
which is close enough for a looping reaction by SfiI on
linear DNA (22). If the SfiI sites on this DNA had been
separated by >10 kb, it is unlikely that its activity would have been
detected. Hence, concerted action at two DNA sites may be a common
feature of the type II restriction endonucleases present in nature but
which have yet to be discovered by in vitro assays.
 |
ACKNOWLEDGEMENTS |
We thank Niall Gormley, Humin Kong, Susan
Milsom, Ira Schildkraut, Virginijus Siksnys, Mark Szczelkun, and Mark
Watson for aid and advice.
 |
FOOTNOTES |
*
This work was supported by grants from the Wellcome Trust
and the Biotechnology and Biological Sciences Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry,
School of Medical Sciences, University of Bristol, University Walk,
Bristol BS8 1TD, UK. Tel.: 44-117-928-7429; Fax: 44-117-928-8274; E-mail: s.halford@bris.ac.uk.
2
L. E. Daniels and S. E. Halford,
manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
bp, base pair;
kb, kilobase pair(s);
MCS, multiple cloning site;
SC, supercoiled;
OC, open
circle;
FFL, full-length linear;
L1 and L2, linear DNA fragments from
the cleavage of a circular DNA with two sites at both sites.
 |
REFERENCES |
| 1.
|
Roberts, R. J.,
and Macelis, D.
(1999)
Nucleic Acids Res.
26,
312-313
|
| 2.
|
Qiang, B-Q.,
and Schildkraut, I.
(1987)
Methods Enzymol.
155,
15-21[Medline]
[Order article via Infotrieve]
|
| 3.
|
Naito, T.,
Kusano, K.,
and Kobayashi, I.
(1995)
Science
267,
897-899[Abstract/Free Full Text]
|
| 4.
|
Wilson, G. G.,
and Murray, N. E.
(1991)
Annu. Rev. Genet.
19,
585-627[CrossRef]
|
| 5.
|
Kobayashi, I.
(1996)
in
Epigenetic Mechanisms of Gene Regulation
(Russo, V.
, Martienssen, R.
, and Riggs, A., eds)
, pp. 155-172, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 6.
|
Dorner, L. F.,
Bitinaite, J.,
Whitaker, R. D.,
and Schildkraut, I.
(1999)
J. Mol. Biol.
285,
1515-1523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Baldwin, G. S.,
Sessions, R. B.,
Erskine, S. G.,
and Halford, S. E.
(1999)
J. Mol Biol.
288,
87-104[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Sasnauskas, G.,
Jeltsch, A,
Pingoud, A.,
and Siksnys, V.
(1999)
Biochemistry
38,
4028-4036[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Horton, J. R.,
Nastri, H. G.,
Riggs, P. D.,
and Cheng, X.
(1998)
J. Mol. Biol.
284,
1491-1504[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Cao, W.
(1999)
Biochemistry
38,
8080-8087[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Roberts, R. J.,
and Halford, S. E.
(1993)
in
Nucleases
(Linn, S. M.
, Lloyd, R. S.
, and Roberts, R. J., eds)
, pp. 35-88, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 12.
|
Terry, B. J.,
Jack, W. E.,
and Modrich, P.
(1985)
J. Biol. Chem.
260,
13130-13137[Abstract/Free Full Text]
|
| 13.
|
Terry, B. J.,
Jack, W. E.,
and Modrich, P.
(1987)
Gene Amplif. Anal.
5,
103-118[Medline]
[Order article via Infotrieve]
|
| 14.
|
Krüger, D. H.,
Barcak, G. J.,
Reuter, M.,
and Smith, H. O.
(1988)
Nucleic Acids Res.
16,
3997-4008[Abstract/Free Full Text]
|
| 15.
|
Yang, C. C.,
and Topal, M. D.
(1992)
Biochemistry
31,
9657-9664[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Gabbara, S.,
and Bhagwat, A. S.
(1992)
J. Biol. Chem.
267,
18623-18630[Abstract/Free Full Text]
|
| 17.
|
Baxter, B. K.,
and Topal, M. D.
(1993)
Biochemistry
32,
8291-8298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Reuter, M.,
Kupper, D.,
Meisel, A.,
Schroeder, C.,
and Krüger, D. H.
(1998)
J. Biol. Chem.
273,
8294-8300[Abstract/Free Full Text]
|
| 19.
|
Pein, C-D.,
Reuter, M.,
Meisel, A.,
Cech, D.,
and Krüger, D. H.
(1991)
Nucleic Acids Res.
19,
5139-5142[Abstract/Free Full Text]
|
| 20.
|
Conrad, M.,
and Topal, M. D.
(1992)
Nucleic Acids Res.
20,
5127-5130[Abstract/Free Full Text]
|
| 21.
|
Wentzell, L. M.,
Nobbs, T. J.,
and Halford, S. E.
(1995)
J. Mol. Biol.
248,
581-595[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Nobbs, T. J.,
and Halford, S. E.
(1995)
J. Mol. Biol.
252,
399-411[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Szczelkun, M. D.,
and Halford, S. E.
(1996)
EMBO J.
15,
1460-1469[Medline]
[Order article via Infotrieve]
|
| 24.
|
Nobbs, T. J.,
Williams, S. A.,
Connolly, B. A.,
and Halford, S. E.
(1998)
Biol. chem.
379,
599-604[Medline]
[Order article via Infotrieve]
|
| 25.
|
Nobbs, T. J.,
Szczelkun, M. D.,
Wentzell, L. M.,
and Halford, S. E.
(1998)
J. Mol. Biol.
281,
419-432[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Wentzell, L. M.,
and Halford, S. E.
(1998)
J. Mol. Biol.
281,
433-444[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Embleton, M. L.,
Williams, S. A.,
Watson, M. A.,
and Halford, S. E.
(1999)
J. Mol. Biol.
289,
785-797[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Rippe, K.,
von Hippel, P. H.,
and Langowski, J.
(1995)
Trends Biochem. Sci.
20,
500-506[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Hallet, B.,
and Sherratt, D. J.
(1997)
FEMS Microbiol. Rev.
21,
157-178[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bilcock, D. T.,
and Halford, S. E.
(1999)
Mol. Microbiol.
31,
1243-1254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Grasby, J. A.,
and Connolly, B. A.
(1992)
Biochemistry
31,
7855-7861[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Mizuuchi, K.,
Nobbs, T. J.,
Halford, S. E.,
Adzuma, K.,
and Qin, J.
(1999)
Biochemistry
38,
4640-4648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Qiang, B-Q.,
and Schildkraut, I.
(1984)
Nucleic Acids Res.
12,
4507-4516[Abstract/Free Full Text]
|
| 34.
|
Twigg, A. J.,
and Sherratt, D. J.
(1980)
Nature
283,
216-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Yanisch-Perron, C.,
Viera, C.,
and Messing, J.
(1985)
Gene (Amst.)
33,
103-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Sambrook, J. C.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 37.
|
Kelleher, J. E.,
and Raleigh, E. A.
(1994)
J. Bacteriol.
176,
5888-5896[Abstract/Free Full Text]
|
| 38.
|
Halford, S. E.,
Taylor, J. D.,
Vermote, C. L. M.,
and Vipond, I. B.
(1994)
Methods Mol. Biol.
30,
385-396[Medline]
[Order article via Infotrieve]
|
| 39.
|
Erskine, S. G.,
Baldwin, G. S.,
and Halford, S. E.
(1997)
Biochemistry
36,
7567-7576[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Gutfreund, H.
(1995)
Kinetics for the Life Sciences
, Cambridge University Press, Cambridge, UK
|
| 41.
|
Thomas, M.,
and Davis, R. W.
(1975)
J. Mol. Biol.
91,
314-328
|
| 42.
|
Halford, S. E.,
Johnson, N. P.,
and Grinsted, J.
(1980)
Biochem. J.
191,
581-592[Medline]
[Order article via Infotrieve]
|
| 43.
|
Taylor, J. D.,
and Halford, S. E.
(1992)
Biochemistry
28,
6198-6207
|
| 44.
|
Oram, M.,
Marko, J. F.,
and Halford, S. E.
(1997)
J. Mol. Biol.
270,
396-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Jian, H.,
Schlick, T.,
and Vologodskii, A.
(1998)
J. Mol. Biol.
284,
287-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Maxwell, A.,
and Halford, S. E.
(1980)
Biochem. J.
203,
85-92
|
| 47.
|
Siksnys, V.,
Skirgaila, R.,
Sasnauskas, G.,
Urbanke, C.,
Cherny, D.,
Grazulis, S.,
and Huber, R.
(1999)
J. Mol. Biol.
291,
1105-1118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Bozic, D.,
Grazulis, S.,
Siksnys, V.,
and Huber, R.
(1996)
J. Mol. Biol.
255,
176-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Meisel, A.,
Bickle, T. A.,
Krüger, D. H.,
and Schroeder, C.
(1992)
Nature
355,
467-469[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Penne, D.,
Raleigh, E. A.,
and Bickle, T. A.
(1999)
J. Mol. Biol.
290,
49-60[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Szczelkun, M. D.,
Dillingham, M. S.,
Janscak, P.,
Firman, K.,
and Halford, S. E.
(1996)
EMBO J.
15,
6335-6347[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea